Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Lung Cancer

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 52 articles:
HTML format



Single Articles


    July 2025
  1. WALLIS N, Gershon T, Shaaby S, Oberman F, et al
    AVJ16 inhibits lung carcinoma by targeting IGF2BP1.
    Oncogene. 2025 Jul 8. doi: 10.1038/s41388-025-03449.
    PubMed     Abstract available


  2. TAN X, Wu C, Banerjee P, Wang S, et al
    Dichotomous roles of ACBD3 in NSCLC growth and metastasis.
    Oncogene. 2025;44:2078-2090.
    PubMed     Abstract available


  3. TAKUMIDA H, Saito A, Okabe Y, Terasaki Y, et al
    Integrative epigenome and transcriptome analyses reveal transcriptional programs differentially regulated by ASCL1 and NEUROD1 in small cell lung cancer.
    Oncogene. 2025 Jul 1. doi: 10.1038/s41388-025-03481.
    PubMed     Abstract available


  4. OH YT, Chen Z, Wang D, Ramalingam SS, et al
    Induction of IL6/STAT3-dependent TRAIL expression that contributes to the therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells.
    Oncogene. 2025;44:2315-2327.
    PubMed     Abstract available


    June 2025
  5. LI S, Lin J, Huang L, Hu S, et al
    STK31 drives tumor immune evasion through STAT3-IL-6 mediated CD8(+) T cell exhaustion.
    Oncogene. 2025;44:1452-1462.
    PubMed     Abstract available


  6. POIRIER A, Utecht T, Villot R, Gelinas Y, et al
    ZNF768 loss amplifies p53 action and reduces lung tumorigenesis in mice.
    Oncogene. 2025;44:1793-1804.
    PubMed     Abstract available


    May 2025
  7. WANG C, Zhang S, Ma B, Fu Y, et al
    Correction: TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression.
    Oncogene. 2025 May 14. doi: 10.1038/s41388-025-03441.
    PubMed    


  8. WANG T, Shen Z, Yang L, Zhang X, et al
    The coagulation and tumor system are directly linked through the proteolysis and activation of epidermal growth factor receptor by thrombin.
    Oncogene. 2025;44:1153-1166.
    PubMed     Abstract available


  9. ZHANG C, Zhou W, Xu H, Xu J, et al
    Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop.
    Oncogene. 2025;44:1400-1414.
    PubMed     Abstract available


    April 2025
  10. LIU X, Cui Y, Gong J, Yu X, et al
    SETD5 facilitates stemness and represses ferroptosis via m6A-mediating PKM2 stabilization in non-small cell lung cancer.
    Oncogene. 2025 Apr 30. doi: 10.1038/s41388-025-03426.
    PubMed     Abstract available


  11. GAO Y, Li B, Jin Y, Cheng J, et al
    Spatial multi-omics profiling of breast cancer oligo-recurrent lung metastasis.
    Oncogene. 2025 Apr 15. doi: 10.1038/s41388-025-03388.
    PubMed     Abstract available


  12. XU X, Wang S, Zhou H, Tan Q, et al
    Transcriptome-wide association study of alternative polyadenylation identifies susceptibility genes in non-small cell lung cancer.
    Oncogene. 2025 Apr 9. doi: 10.1038/s41388-025-03338.
    PubMed     Abstract available


    March 2025
  13. ZHANG S, Tan YQ, Zhang X, Basappa B, et al
    TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinoma.
    Oncogene. 2025;44:753-768.
    PubMed     Abstract available


    February 2025
  14. LI H, Li Y, Zheng X, Chen F, et al
    RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1.
    Oncogene. 2025;44:307-321.
    PubMed     Abstract available


    January 2025
  15. ZEESHAN S, Dalal B, Arauz RF, Zingone A, et al
    Global profiling of alternative splicing in non-small cell lung cancer reveals novel histological and population differences.
    Oncogene. 2025 Jan 10. doi: 10.1038/s41388-024-03267.
    PubMed     Abstract available


  16. TYAGI A, Wu SY, Sharma S, Wu K, et al
    Retraction Note: Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis.
    Oncogene. 2025 Jan 9. doi: 10.1038/s41388-024-03269.
    PubMed    


    December 2024
  17. LEI Y, Zhong C, Zhang J, Zheng Q, et al
    Senescent lung fibroblasts in idiopathic pulmonary fibrosis facilitate non-small cell lung cancer progression by secreting exosomal MMP1.
    Oncogene. 2024 Dec 11. doi: 10.1038/s41388-024-03236.
    PubMed     Abstract available


  18. TANG T, Yang T, Xue H, Liu X, et al
    Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis.
    Oncogene. 2024 Dec 4. doi: 10.1038/s41388-024-03237.
    PubMed     Abstract available


  19. CHEN Y, Zhu X, Wang J, Hu J, et al
    MAZ promotes tumor proliferation and immune evasion in lung adenocarcinoma.
    Oncogene. 2024;43:3619-3632.
    PubMed     Abstract available


    November 2024
  20. CHEN T, Ashwood LM, Kondrashova O, Strasser A, et al
    Breathing new insights into the role of mutant p53 in lung cancer.
    Oncogene. 2024 Nov 20. doi: 10.1038/s41388-024-03219.
    PubMed     Abstract available


  21. NIU Y, Tang Y, Ma F, Zhou X, et al
    Super-enhancer MYCNOS-SE promotes chemoresistance in small cell lung cancer by recruiting transcription factors CTCF and KLF15.
    Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03202.
    PubMed     Abstract available


    September 2024
  22. LAILLER C, Didelot A, Garinet S, Berthou H, et al
    PrP(C) controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up.
    Oncogene. 2024;43:2781-2794.
    PubMed     Abstract available


  23. HAN P, Zhang B, Li Y, Gao R, et al
    MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting hypoxia adaptation mediated by HIF-1alpha/NDUFA4L2 axis.
    Oncogene. 2024;43:2821-2834.
    PubMed     Abstract available


    August 2024
  24. NGUYEN A, Nunez CG, Tran TA, Girard L, et al
    Jumonji histone demethylases are therapeutic targets in small cell lung cancer.
    Oncogene. 2024 Aug 18. doi: 10.1038/s41388-024-03125.
    PubMed     Abstract available


  25. CHEN X, Zhou J, Wang Y, Wang X, et al
    PIM1/NF-kappaB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC.
    Oncogene. 2024;43:2517-2530.
    PubMed     Abstract available


  26. SHEN NX, Luo MY, Gu WM, Gong M, et al
    GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma.
    Oncogene. 2024;43:2504-2516.
    PubMed     Abstract available


    July 2024
  27. WANG Z, Lei Z, Wang Y, Wang S, et al
    Bone-metastatic lung adenocarcinoma cells bearing CD74-ROS1 fusion interact with macrophages to promote their dissemination.
    Oncogene. 2024;43:2215-2227.
    PubMed     Abstract available


    June 2024
  28. JIN E, Wang S, Chen D, Wang JP, et al
    P4HA2 activates mTOR via hydroxylation and targeting P4HA2-mTOR inhibits lung adenocarcinoma cell growth.
    Oncogene. 2024;43:1813-1823.
    PubMed     Abstract available


  29. LI QQ, Guo M, He GH, Xi KH, et al
    VEGF-induced Nrdp1 deficiency in vascular endothelial cells promotes cancer metastasis by degrading vascular basement membrane.
    Oncogene. 2024;43:1836-1851.
    PubMed     Abstract available


  30. WANG K, Guo D, Yan T, Sun S, et al
    ZBTB16 inhibits DNA replication and induces cell cycle arrest by targeting WDHD1 transcription in lung adenocarcinoma.
    Oncogene. 2024;43:1796-1810.
    PubMed     Abstract available


  31. CHEN L, Zhang L, He H, Shao F, et al
    Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation.
    Oncogene. 2024;43:2025-2037.
    PubMed     Abstract available


    May 2024
  32. DORE S, Ali M, Sorin M, McDowell SAC, et al
    Exploring the prognostic significance of arm-level copy number alterations in triple-negative breast cancer.
    Oncogene. 2024 May 14. doi: 10.1038/s41388-024-03051.
    PubMed     Abstract available


    April 2024
  33. WANG X, Li X, Niu L, Lv F, et al
    FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer.
    Oncogene. 2024 Apr 9. doi: 10.1038/s41388-024-03027.
    PubMed     Abstract available


  34. ZHANG T, Su F, Wang B, Liu L, et al
    Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma.
    Oncogene. 2024;43:1190-1202.
    PubMed     Abstract available


    March 2024
  35. GUO J, Kim D, Gao J, Kurtyka C, et al
    Retraction Note: IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.
    Oncogene. 2024 Mar 5. doi: 10.1038/s41388-024-02993.
    PubMed    


  36. XU X, Qiu S, Zeng B, Huang Y, et al
    N(6)-methyladenosine demethyltransferase FTO mediated m(6)A modification of estrogen receptor alpha in non-small cell lung cancer tumorigenesis.
    Oncogene. 2024 Mar 5. doi: 10.1038/s41388-024-02992.
    PubMed     Abstract available


  37. KUMAR V, Yochum ZA, Devadassan P, Huang EH, et al
    TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer.
    Oncogene. 2024 Mar 1. doi: 10.1038/s41388-024-02987.
    PubMed     Abstract available


  38. MCCLELLAN B, Wilson CN, Brenner AJ, Jolly CA, et al
    Flotillin-1 palmitoylation is essential for its stability and subsequent tumor promoting capabilities.
    Oncogene. 2024;43:1063-1074.
    PubMed     Abstract available


  39. HEIM TE, Hankins ML, Belayneh R, Douglas N, et al
    RNA-sequencing predicts a role of androgen receptor and aldehyde dehydrogenase 1A1 in osteosarcoma lung metastases.
    Oncogene. 2024;43:1007-1018.
    PubMed     Abstract available


    February 2024
  40. GAROFALO M, Quintavalle C, Di Leva G, Zanca C, et al
    Editorial Expression of Concern: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer.
    Oncogene. 2024 Feb 28. doi: 10.1038/s41388-024-02989.
    PubMed    


  41. TURKOWSKI K, Herzberg F, Gunther S, Weigert A, et al
    miR-147b mediated suppression of DUSP8 promotes lung cancer progression.
    Oncogene. 2024 Feb 23. doi: 10.1038/s41388-024-02969.
    PubMed     Abstract available


    January 2024
  42. ZHANG Y, Liu L, Pei J, Ren Z, et al
    Tissue factor overexpression promotes resistance to KRAS-G12C inhibition in non-small cell lung cancer.
    Oncogene. 2024 Jan 8. doi: 10.1038/s41388-023-02924.
    PubMed     Abstract available


  43. OSER MG, MacPherson D, Oliver TG, Sage J, et al
    Genetically-engineered mouse models of small cell lung cancer: the next generation.
    Oncogene. 2024 Jan 8. doi: 10.1038/s41388-023-02929.
    PubMed     Abstract available


  44. MA M, Zhuang J, Li H, Mi R, et al
    Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-beta signaling feedback loop.
    Oncogene. 2024;43:47-60.
    PubMed     Abstract available


    December 2023
  45. WANG L, Li H, Huang A, Zhao Y, et al
    Mutual regulation between TRIM21 and TRIM8 via K48-linked ubiquitination.
    Oncogene. 2023;42:3708-3718.
    PubMed     Abstract available


    November 2023
  46. CHEN W, Wang F, Yu X, Qi J, et al
    LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression.
    Oncogene. 2023 Nov 10. doi: 10.1038/s41388-023-02883.
    PubMed     Abstract available


  47. KOU F, Wu L, Zheng Y, Yi Y, et al
    HMGB1/SET/HAT1 complex-mediated SASH1 repression drives glycolysis and metastasis in lung adenocarcinoma.
    Oncogene. 2023;42:3407-3421.
    PubMed     Abstract available


  48. SUN X, Dai Y, He J, Li H, et al
    D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC.
    Oncogene. 2023;42:3503-3513.
    PubMed     Abstract available


    October 2023
  49. BAI Y, Zhou L, Zhang C, Guo M, et al
    Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer.
    Oncogene. 2023 Oct 20. doi: 10.1038/s41388-023-02866.
    PubMed     Abstract available


  50. LIU Y, Zhang T, Deng J, Huang Q, et al
    The cytotoxicity of (gammadelta)T cells in non-small cell lung cancer mediated via coordination of the BCL-2 and AKT pathways.
    Oncogene. 2023 Oct 7. doi: 10.1038/s41388-023-02852.
    PubMed     Abstract available


  51. WANG Y, Liu X, Wang M, Wang Y, et al
    UBE3B promotes breast cancer progression by antagonizing HIF-2alpha degradation.
    Oncogene. 2023 Oct 2. doi: 10.1038/s41388-023-02842.
    PubMed     Abstract available


  52. CUI P, Li J, Tao H, Li X, et al
    Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis.
    Oncogene. 2023;42:3098-3112.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.